These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8693527)

  • 21. Donor cell microchimerism in kidney transplantation: Implications for graft function.
    El-Ansary M; Saadi G; Hassaballa M; Zidan M; Abdel Fattah W; Kelany AK; Hanna MOF
    Int J Immunogenet; 2020 Dec; 47(6):494-500. PubMed ID: 32881306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of microchimerism in rat liver transplantation by polymerase chain reaction.
    Tashiro H; Fukuda Y; Kimura A; Hoshino S; Ito H; Dohi K
    Hepatology; 1996 Apr; 23(4):828-34. PubMed ID: 8666338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Zucker K; Cirocco R; Ciancio G; Burke G; Roth D; Temple D; Rosen A; Fuller L; Esquenazi V; Karatzas T; Ricordi C; Tzakis A; Miller J
    J Clin Invest; 1997 Mar; 99(5):1118-29. PubMed ID: 9062371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry.
    Garcia-Morales R; Esquenazi V; Zucker K; Gomez CI; Fuller L; Carreno M; Cirocco R; Alamo A; Karatzas T; Burke GW; Ciancio G; Temple D; Fernandez H; Ricordi C; Tzakis A; Miller J
    Transplantation; 1996 Oct; 62(8):1149-60. PubMed ID: 8900317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of donor antigen-specific hyporeactivity with allogeneic microchimerism in kidney and lung recipients.
    Reinsmoen NL; McSherry C; Chavers B; Hertz MI; Matas AJ
    Pediatr Nephrol; 1995; 9 Suppl():S35-9. PubMed ID: 7492484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 12-day course of FK506 allows long-term acceptance of semi-identical liver allograft in inbred miniature swine.
    Oike F; Talpe S; Otsuka M; Dehoux JP; Lerut J; Otte JB; Gianello P
    Transplantation; 2000 Jun; 69(11):2304-14. PubMed ID: 10868630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Better clinical outcome in renal transplant recipients with peripheral blood microchimerism.
    Sakamoto K; Arita S; Sakamaki T; Yamada H; Kusume K; Yoshida T; Okazaki Y; Yamada K; Gunji Y; Shimada H; Ochiai T; Kashiwabara H; Yokoyama T
    Transplant Proc; 2000 Nov; 32(7):1793-4. PubMed ID: 11119940
    [No Abstract]   [Full Text] [Related]  

  • 28. Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism.
    Shirwan H; Wang HK; Barwari L; Makowka L; Cramer DV
    Transplantation; 1996 May; 61(9):1382-6. PubMed ID: 8629301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allogeneic microchimerism and donor antigen-specific hyporeactivity in lung transplant recipients.
    McSherry C; Hertz MI; Jackson AM; Butters K; Diko M; Matas AJ; Bolman RM; Reinsmoen NL
    Clin Transplant; 1995 Dec; 9(6):442-9. PubMed ID: 8645886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donor-derived peripheral mononuclear cell DNA is associated with stable kidney allograft function: a randomized controlled trial.
    Solgi G; Mytilineos J; Gadi V; Paul B; Pourmand G; Mehrsai A; Nikbin B; Amirzargar AA
    Chimerism; 2011; 2(4):102-10. PubMed ID: 22509426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early hematopoietic microchimerism predicts clinical outcome after kidney transplantation.
    Pujal JM; Grinyó JM; Gil-Vernet S; Caldes A; Hernández P; Mestre M; Encuentra M; Perez-Garcia A; Gallardo D
    Transplantation; 2007 Nov; 84(9):1103-11. PubMed ID: 17998864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor type microchimerism is an infrequent event following liver transplantation and is not associated with graft acceptance.
    Norris S; Lawler M; McCann S; Hegarty J; O'Farrelly C
    Hepatology; 1997 Oct; 26(4):848-52. PubMed ID: 9328303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Cirocco R; Zucker K; Ciancio G; Burke G; Roth D; Temple D; Fuller L; Esquenazi V; Eskind L; Kenyon NS; Ricordi C; Tzakis A; Miller J
    Transplantation; 1998 Apr; 65(7):956-65. PubMed ID: 9565101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donor bone marrow-derived chimeric cells present in renal transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses.
    Mathew JM; Garcia-Morales R; Fuller L; Rosen A; Ciancio G; Burke GW; Carreno M; Temple D; Tzakis AG; Ricordi C; Miller J; Esquenazi V
    Transplantation; 2000 Dec; 70(12):1675-82. PubMed ID: 11152096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation.
    Starzl TE; Demetris AJ; Trucco M; Zeevi A; Ramos H; Terasaki P; Rudert WA; Kocova M; Ricordi C; Ildstad S
    Transplantation; 1993 Jun; 55(6):1272-7. PubMed ID: 8516813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral blood microchimerism does not correlate with the state of graft acceptance in HLA-DRB1 mismatched renal transplant recipients.
    Sakamoto K; Matsushita K; Sakamaki T; Yamada K; Gunji Y; Yamada H; Kashiwabara H; Yokoyama T
    Transplant Proc; 1998 Feb; 30(1):7-8. PubMed ID: 9474939
    [No Abstract]   [Full Text] [Related]  

  • 37. Microchimerism in peripheral blood and urine in renal transplant recipients: preliminary results.
    Fourtounas C; Spyridonidis A; Dousdampanis P; Savidaki E; Kalliakmani P; Papachristou E; Goumenos D; Vlachojannis JG
    Transplant Proc; 2008 Dec; 40(10):3434-6. PubMed ID: 19100406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early microchimerism in peripheral blood following kidney transplantation.
    Kishikawa H; Kinoshita T; Yonemoto S; Kawamura M; Nakazawa S; Ueda N; Hirai T; Nishimura K; Hashimoto M; Ichikawa Y
    Transplant Proc; 2014; 46(2):388-90. PubMed ID: 24655970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients.
    Ciancio G; Burke GW; Garcia-Morales R; Suzart K; Rosen A; Ricordi C; Kenyon NS; Mathew JM; Tzakis AG; Esquenazi V; Miller J
    Transplantation; 2002 Aug; 74(4):488-96. PubMed ID: 12352907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of microchimerism in long-term tolerant living-donor kidney graft recipients.
    Garnier JL; Daoud S; Favre-Victoire I; Cozon G; Boulez J; Dubernard JM; Betuel H; Touraine JL; Gebuhrer L
    Transplant Proc; 1996 Oct; 28(5):2834. PubMed ID: 8908087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.